Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: time for a sit-down

Is it also possible that TPL, being aware of any of Moore's possible idiosyncrasies, thought it best to have it included?

All that can be stated as fact is PTSC has 50% ownership. Moore states he owns the other 50% but that is currently pending the arbitration for which there has been no available input from TPL with which to compare and contrast..

.

.

Be well

Share
New Message
Please login to post a reply